Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Tamoxifen is an antagonist of the estrogen receptor and currently used for the treatment of breast cancer. The current treatment of cutaneous leishmaniasis with pentavalent antimony compounds is not satisfactory. Therefore, in this study, due to its antileishmanial activity, effects of tamoxifen on the growth of promastigotes and amastigotes of Leishmania major Iranian strain were evaluated in vitro. Promastigotes and amastigotes were treated with different concentrations (1, 5, 10, 20, and 50 μg/ml) and time periods (24, 48, and 72 hr) of tamoxifen. After tamoxifen treatment, MTT assay (3-[4,5-dimethylthiazol-2-yl]-2,5 biphenyl tetrazolium bromide assay) was used to determine the percentage of live parasites and Graph Pad Prism software to calculate IC50. Flow cytometry was applied to investigate the induction of tamoxifen-induced apoptosis in promastigotes. The half maximal inhibitory concentration (IC50) of tamoxifen on promastigotes was 2.6 μg/ml after 24 hr treatment. Flow cytometry analysis showed that tamoxifen induced early and late apoptosis in Leishmania promastigotes. While after 48 hr in control group the apoptosis was 2.0%, the 50 µg/L concentration of tamoxifen increased it to 59.7%. Based on the in vitro antileishmanial effect, tamoxifen might be used for leishmaniasis treatment; however, further researches on in vivo effects of tamoxifen in animal models are needed.
Abstract
Tamoxifen is an antagonist of the estrogen receptor and currently used for the treatment of breast cancer. The current treatment of cutaneous leishmaniasis with pentavalent antimony compounds is not satisfactory. Therefore, in this study, due to its antileishmanial activity, effects of tamoxifen on the growth of promastigotes and amastigotes of Leishmania major Iranian strain were evaluated in vitro. Promastigotes and amastigotes were treated with different concentrations (1, 5, 10, 20, and 50 μg/ml) and time periods (24, 48, and 72 hr) of tamoxifen. After tamoxifen treatment, MTT assay (3-[4,5-dimethylthiazol-2-yl]-2,5 biphenyl tetrazolium bromide assay) was used to determine the percentage of live parasites and Graph Pad Prism software to calculate IC50. Flow cytometry was applied to investigate the induction of tamoxifen-induced apoptosis in promastigotes. The half maximal inhibitory concentration (IC50) of tamoxifen on promastigotes was 2.6 μg/ml after 24 hr treatment. Flow cytometry analysis showed that tamoxifen induced early and late apoptosis in Leishmania promastigotes. While after 48 hr in control group the apoptosis was 2.0%, the 50 µg/L concentration of tamoxifen increased it to 59.7%. Based on the in vitro antileishmanial effect, tamoxifen might be used for leishmaniasis treatment; however, further researches on in vivo effects of tamoxifen in animal models are needed.
참고문헌 (21)
- World Health Organization, "Control of the leishmaniases", Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases (2010)
- Doroodgar A, "Progressive increasing of cutaneous leishmaniasis in Kashan district, central of Iran", Asian Pac J Trop Dis, 2, pp.260~263 (2012)
- Desjeux P, "Leishmaniasis : current situation and new perspectives", Comp Immunol Microbiol Infect Dis, 27, pp.305~318 (2004)
- Croft SL, "Leishmaniasis–current chemotherapy and recent advances in the search for novel drugs", Trends Parasitol, 19, pp.502~508 (2003)
- Croft SL, "Chemotherapy of leishmaniasis", Curr Pharm Des, 8, pp.319~342 (2002)
- Doroodgar A, "Treatment of cutaneous leishmaniasis in murine model by hydro alcoholic essence of Artemisia sieberi", Iranian J Arthropod-Borne Dis, 2, pp.42~47 (2008)
- Eissa MM, "Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis", Exp Parasitol, 128, pp.382~390 (2011)
- Jordan VC, "Tamoxifen: a most unlikely pioneering medicine", Nat Rev Drug Discov, 2, pp.205~513 (2003)
- Beggs WH, "Drug protonation and pH in relation to the lethal action of tamoxifen on Candida albicans", Antimicrob Chemother J, 37, pp.841~842 (1996)
- Drutz DJ, "Human sex hormones stimulate the growth and maturation of Coccidioides immitis", Infect Immun, 32, pp.897~907 (1981)
- Miguel DC, "Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections", Antimicrob Chemother J, 63, pp.365~368 (2009)
- Delavari M, "In vitro study on cytotoxic effects of ZnO nanoparticles on promastigote and amastigote forms of Leishmania major (MRHO", IR, ER), pp.Iranian J Parasitol, 2014[DOI]
- Marufi Y, "Cantharidin-induced apoptosis in Leishmania major promastigotes and macrophages infected by Leishmania major amastigotes in-vitro", J Mazand Univ Med Sci J, 22, pp.33~40 (2012)
- Rocha LG, "A review of natural products with antileishmanial activity", Phytomedicine, 12, pp.514~535 (2005)
- Nari Y, "Protective effect of Aloe vera on polymicrobial sepsis in mice", Food Chem Toxicol, 47, pp.1341~1348 (2009)
- Dutta A, "In vitro antileishmanial activity of Aloe vera leaf exudate : a potential herbal therapy in leishmaniasis", Glycoconj J, 24, pp.81~86 (2007)
- Choi SW, "The wound-healing effect of a glycoprotein fraction isolated from Aloe vera", Br J Dermatol, 145, pp.535~545 (2001)
- Ebrahimi SP, "The effect of artemether-induced apoptosis in promastigotes of Leishmania major (MRHO", IR, ER) under in-vitro conditions, pp.Modares J Med Sci Pathol, 2012[DOI]
- Caroline P, "Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes", Antimicrob Agents Chemother, 48, pp.852~859 (2004)
- Miguel DC, "Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice", PLoS Negl Trop Dis, 2, pp.249~ (2008)
- Trinconi CT, "Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis", Antimicrob Agents Chemother, 58, pp.2608~2613 (2014)